We first used online databases and found that SIRT6 is upregulated in lung cancer, and the overall survival of lung cancer patients with high SIRT6 expression is shorter, suggesting that SIRT6 is associated with poor prognosis of lung cancer, especially EGFR mutant NSCLC. Here, EGFR is linked to lung carcinoma.